Valor Sciences

BPC-157 10 mg

In stock

$70.00

Synthetic pentadecapeptide supplied as a 10 mg lyophilized powder.
≥99% purity verified by HPLC.
Manufactured for controlled laboratory research applications.
For Research Use Only. Not for human or veterinary use.

In stock

Earn 350 Points when you buy this product!
Buy It Now
Storage & Handling
  • Ships lyophilized at ambient temperature—stable during transit
  • Store at –20°C or below upon receipt
  • Reconstituted solutions: refrigerate (2-8°C), use within 5-10 days
  • Aliquot to minimize freeze-thaw cycles
Research Use Only
  • Supplied for in-vitro laboratory research only
  • Not approved for diagnostic, therapeutic, or dietary use
  • Not for human or veterinary use
SKU: BPC-157 10MG Categories: , , Tag: Brands:

Description

BPC-157 Research Peptide | 10mg

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of a ~40 kDa protein first isolated from human gastric juice. This 15-amino acid fragment has been extensively characterized in peer-reviewed in-vitro and animal model research spanning three decades.

Structural Characteristics

BPC-157 is a linear peptide lacking disulfide bonds. Its remarkable stability derives primarily from four proline residues at positions 3, 4, 5, and 8, including a distinctive triple-proline motif (PPP). This proline-rich sequence introduces conformational rigidity that strongly resists proteolytic degradation by trypsin, chymotrypsin, and catheptic proteases. BPC-157 remains stable in human gastric juice for more than 24 hours—an exceptionally long duration compared to most peptides.

Characterized Signaling Pathways

Published research has identified multiple cellular signaling interactions:

Nitric Oxide System: Research by Hsieh et al. (Scientific Reports, 2020) demonstrated that BPC-157 induces phosphorylation of eNOS at Ser1177 through the Src-Caveolin-1-eNOS signaling cascade, reducing inhibitory Cav-1-eNOS complex formation and enabling NO production.

VEGFR2 Pathway: Studies show BPC-157 upregulates VEGFR2 mRNA and protein expression in vascular endothelial cells, promoting receptor internalization and activating downstream VEGFR2-Akt-eNOS signaling (Hsieh et al., Journal of Molecular Medicine, 2017).

Growth Hormone Receptor: cDNA microarray analysis identified GHR as abundantly upregulated following BPC-157 treatment, with dose-dependent increases reaching up to 7-fold elevation in both mRNA and protein levels (Chang et al., Molecules, 2014).

FAK-Paxillin Cascade: Western blot analysis confirmed dose-dependent increases in phosphorylation of both FAK and paxillin, correlating with enhanced fibroblast migration and F-actin formation (Chang et al., Journal of Applied Physiology, 2011).

Research Applications

BPC-157 has been utilized as a molecular probe in controlled experimental systems examining:

– Gastrointestinal mucosal integrity models
– Connective tissue and fibroblast behavior
– Tendon and ligament biology
– Angiogenic signaling pathways
– Extracellular matrix dynamics
– Oxidative stress modulation
– Cellular migration mechanisms

Technical Specifications
Product Name BPC-157 (Body Protection Compound-157)
Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Single-Letter Code GEPPPGKPADDAGLV
Form Lyophilized powder
Quantity per Vial 10 mg
Purity ≥98% (HPLC)
Molecular Formula C₆₂H₉₈N₁₆O₂₂
Molecular Weight 1419.56 g/mol
CAS Number 137525-51-0
PubChem CID 9941957
UNII 8ED8NXK95P
Appearance White to off-white powder
Solubility (Water) ~100 mg/mL at 25°C (pH 7.0)
Solubility (DMSO) ~50 mg/mL
Storage –20°C or below
Stability 24 months (if stored as directed)
Valor Sciences BPC-157 10 mg
You're viewing: BPC-157 10 mg $70.00
Add to cart
Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare
shopping cart